Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 29% loss from investing in the stock five years ago [Yahoo! Finance]
HIKMA PHARMS PLC S/ADR (HKMPY)
NASDAQ:AMEX Investor Relations:
hikma.com/en/investors.html
Company Research
Source: Yahoo! Finance
At this point some shareholders may be questioning their investment in Hikma Pharmaceuticals PLC LON:HIK ), since the last five years saw the share price fall 38%. Furthermore, it's down 14% in about a quarter. That's not much fun for holders. Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Looking back five years, both Hikma Pharmaceuticals' share price and EPS declined; the latter at a rate of 4.6% per year. Readers should note that the share price
Show less
Read more
Impact Snapshot
Event Time:
HKMPY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HKMPY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HKMPY alerts
High impacting HIKMA PHARMS PLC S/ADR news events
Weekly update
A roundup of the hottest topics
HKMPY
News
- Looking At The Narrative For Hikma Pharmaceuticals LSE HIK After Analyst Split On Fair Value [Yahoo! Finance]Yahoo! Finance
- Hikma launches TYZAVAN™ (vancomycin injection, USP) in the USPR Newswire
- How Recent Developments Are Shaping the Hikma Pharmaceuticals Story and Its Valuation [Yahoo! Finance]Yahoo! Finance
- Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript [Seeking Alpha]Seeking Alpha
- Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution [Yahoo! Finance]Yahoo! Finance